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Abstract 
Porcine endogenous retroviruses (PERV) represent a risk for xenotransplantation using pig cells, 
tissues or organs. PERV-A and PERV-B are present in the genome of all pigs and both infect human 
cells in vitro. PERV-C infects only pig cells and it is integrated in the genome of most, but not all pigs. 
Recombinants between PERV-A and PERV-C were described that infect human cells and replicate at 
high titres. To avoid such recombinations, PERV-C positive animals should not be used for breeding 
animals suited for xenotransplantation. 
In order to detect PERV-C positive pigs, different methods were developed such as specific PCRs 
using different primers, a highly sensitive nested PCR and a real-time PCR allowing measurement of 
proviral copy numbers. The real-time PCR was found to be useful to discriminate between 
contamination and actual provirus copies. The PCRs were optimized and their sensitivity was 
determined. Screening can be started with PCR1, if the result is negative, PCR2 to PCR5 or the 
nested PCR should be used, if the result is positive, the real-time PCR should be used to exclude 
contaminations. All methods were used to evaluate the prevalence of PERV-C and to identify PERV-C 
free animals. Due to the risk of contamination with cells from other animals testing should be 
performed with blood cells, not with ear biopsies. 
 
1. Introduction 
Pig to human xenotransplantation is a promising approach to alleviate the shortage of human donor 
organs (Ekser and Cooper, 2010). Pigs were selected as the most suitable donor animals because of 
several advantages: (i) similarities in physiology, (ii) they can be modified genetically easily and 
cloned, (iii) their generation time is relatively short, (iv) their litters are large and (v) their breeding 
costs are low. Nevertheless there are three hurdles to overcome: immunological rejection, 
physiological compatibility and microbiological safety (Pierson, 2009). Transgenic and knock-out 
animals were generated to overcome hyperacute and acute rejection ( [Petersen et al., 
2009] and [Klymiuk et al., 2010]). In terms of microbiological safety, most of the potentially zoonotic 
porcine viruses and other microorganisms can be eliminated by qualified pathogen-free breeding ( 
[Tucker et al., 2002] and [Denner, 2008a]). In contrast, porcine endogenous retroviruses (PERV) 
represent a particular risk. PERV-A and PERV-B are integrated in the genome of all pig strains, they 
are released from normal pig cells and infect human cells (Patience et al., 1997). Another PERV, 
PERV-C, infects only pig cells and is not present in all pigs, nevertheless its prevalence appears to be 
relatively high. In a previous study 176 from 181 (92%) animals were found to harbor PERV-C in their 
genome (Dieckhoff et al., 2009). 
Although PERV-C does not infect human cells and therefore does not represent a direct risk for 
xenotransplantation, recombinants between PERV-A and PERV-C have been described in pigs, that 
are able to infect human cells ( [Bartosch et al., 2004] and [Denner, 2008b]). These recombinant 
viruses were characterised by high virus titres compared to the parental PERV-A (Harrison et al., 
2004) and they were found to behave as exogenous viruses integrating de novo into the genome of 
  
pig cells in some organs, mainly the spleen (Dieckhoff et al., 2007), but they were absent from the 
germ line. Since PERV-A/C are characterised by high titre replication and increasing titres after 
passaging on human cells due to genetic alterations in the LTR (Denner et al., 2003), a consensus 
statement of the International Xenotransplantation Association recommended not to use pigs 
harbouring PERV-C for xenotransplantation in order to avoid PERV-A/C recombinations (Denner et 
al., 2009). To select PERV-C free pigs, sensitive methods have to be used. To screen for PERV-C 
free animals in pig colonies different methods including (i) standard PCR methods using five different 
primer pairs, (ii) a sensitive nested PCR and (iii) a real-time PCR allowing estimation of the copy 
number and to detect contaminations are described. 
 
2. Materials and methods 
2.1. Animals and DNA isolation 
Ear biopsies and blood samples were taken from 38 transgenic and non-transgenic pigs at the 
Friedrich Löffler Institute, Mariensee, and from German landrace pigs in animal farms near Frankfurt. 
Transgenic pigs were carrying either human heme oxygenase (hHO-1), human tumour necrosis factor-
alpha inducible gene A20 (hA20), human CD59, human decay-accelerating factor (DAF, CD55) or 
they were alpha 1,3 galactosyltransferase knockout (GalKO) pigs (Petersen et al., 2009). Animals 
were kept with an Ethical Committee approval and according to international standards for animal 
welfare. 
Peripheral blood mononuclear cells (PBMCs) were isolated from blood samples using LSM 1077 
lymphocyte separation medium (PAA, Pasching, Austria) and DNA was isolated using the DNeasy 
blood and tissue kit (Qiagen, Hilgen, Germany). DNA isolation from ear biopsies was performed using 
the same kit and the TissueLyser LT (40 s at 30 Hz) (Qiagen). 
 
2.2. PCR and nested PCR 
In addition to the PCR based on primers published by Takeuchi et al. (1998) (designated PCR1) four 
other PCR setups were developed, based on different primer pairs (PCR2 to PCR5) (Fig. 1, Table 1). 
Furthermore, a nested PCR was developed, based on flanking primers identical to the primers used in 
PCR1 and inner primers identical to the primers used in PCR2 (Fig. 1, Table 1). Reactions were 
performed in a 25 μl volume using the Kapa2G robust PCR Kit (Peqlab, Erlangen, Germany). The 
mixture consisted of 5 μl of 5× PCR-Buffer A (final concentration 1.5 mM MgCl2), additional 0.5 μl 
MgCl2 (25 mM), 0.5 μl dNTPs (10 mM each dNTP), 1.25 μl primer (10 μM) each, 5 μl 5× Enhancer I, 
0.1 μl of Kapa2G polymerase (5 units/μl) and 1–3 μl template (100 ng DNA) filled up to 25 μl with 
nuclease-free water. For the nested PCR 3 μl of the first step PCR product were used. The flanking 
PCR was performed under following cycle conditions: 15 min of pre-incubation at 95 °C and 30 cycles 
in three steps each (94 °C for 30 s, 55 °C for 30 s, 72 °C for 30 s) and 72 °C for 5 min. Cycle 
conditions for the inner PCR were 3 min of pre-incubation at 94 °C and 30 cycles in three steps (94 °C 
for 30 s, 63 °C for 40 s, 72 °C for 30 s) and 72 °C for 10 min. Both PCRs were performed using 100 ng 
DNA from the pig cell line PK15 as a competitor. 
 
2.3. Real-time PCR 
For quantitation of envC-specific proviral DNA the primers real-time for and real-time rev (Table 1, Fig. 
1) were designed. A duplex real-time PCR was performed based on cyclophilin (cyp) as reference 
gene using the primers cyp real-time for and cyp real-time rev and quantifying the PCR with a cyp 
probe (Table 1). The 25 μl reaction mixture consisted of 2.5 μl 10× PCR buffer (100 mM Tris–HCl, 
500 mM KCl, 15 mM MgCl2, 0.01% (w/v) gelatin), 3 μl MgCl2 (25 mM), 0.5 μl dNTP (20 mM), 0.5 μl 
(10 μM) of each primer, 0.5 μl of both probes (10 μM), 0.1 μl ROX (Invitrogen, Darmstadt, Germany), 
0.3 μl AmpliTaq Gold
®
 polymerase (Roche, Mannheim, Germany) (5 U/μl), nuclease free water and 
the template DNA (100 ng). The thermal cycling conditions used were 7 min at 95 °C followed by 50 
cycles of 95 °C for 20 s and 58 °C for 30 s in a Stratagene MX4000 machine, the quantitative real-time 
PCR software was used (Agilent, Waldbronn, Germany). Efficacy was calculated by measuring ten 
fold serial dilutions of genomic envC positive DNA from 1.1 × 10
10
 to 0.2 plasmid copies per reaction. 
  
Amplicons generated by real-time PCR were subcloned into the vector pBluescript II KS (Agilent, 




Amplicons generated by PCR3 as indicated in Fig. 1 were sequenced bidirectionaly using Sanger's 
dideoxy method, using 10 ng of amplicon, 5 pmol of primer, 1 μl of 5× Buffer 2 μl of BigDye (Applied 
Biosystems), and the corresponding primers. 
 
3. Results 
3.1. Characterisation and sensitivity of the PCR and nested PCR 
To screen animals for PERV-C provirus integration, a standard PCR (PCR1) was used, employing the 
differences in the sequences in the receptor-binding site between PERV-A, PERV-B and PERV-C 
(Takeuchi et al., 1998) (Fig. 1). The sensitivity of the PCR1 was estimated to be 1.1 × 10
4
 copies per 
genome using the molecular clone PERV-C(1312) (Preuss et al., 2006) (Fig. 2A). To increase the 
sensitivity of nucleic acid amplifications, a nested PCR was developed, using flanking primers identical 
to the primers used in PCR1 and two inner primers. The sensitivity of the nested PCR was estimated 
by serial dilutions to be 1–0.6 copies per genome using molecular clone PERV-C(1312) in the 
presence of DNA from the pig cell line PK15 (Fig. 2B). To exclude false-negative results due to 
mutations in the primer binding sites, three additional PERV-C-specific PCRs such as PCR2, using the 
inner primers of the nested PCR, PCR3, PCR4 and PCR 5 were developed (Table 1, Fig. 1). 
When DNA samples from 38 transgenic and non-transgenic pigs were analysed, 35 of them (92%) 
were positive in PCR1, 2 and 3 (Table 2), indicating that the PCRs gave the same result and that 
these animals were PERV-C positive. PCR4 was not applied knowing that it gives the same result as 
PCR1 (Dieckhoff et al., 2009). When DNA from 8 animals were tested using PCR5, the results were 
the same as obtained with PCR1-3. 
When the DNA from animals negative for PERV-C according to PCR1-3 were analysed using the 
highly sensitive nested PCR, the results remained negative. However, when ear biopsies and blood 
from the same animal were tested using the nested PCR, in some cases DNA from ear biopsies was 
positive whereas DNA from PBMCs was negative for PERV-C proviruses. The reason for the false 
positive results was certainly the presence of cells from neighbour animals on the skin of the animals 
or contaminations by the instrument used to take the biopsies (this will be confirmed below by real-
time PCR). Since the contamination was low and not detected by standard PCR, these results also 
underline the high sensitivity of the nested PCR. 
 
3.2. Characterisation and sensitivity of the real-time PCR 
To quantify the number of integrated PERV-C proviruses, a real-time PCR was established. Primers 
and a probe were designed in a region specific for PERV-C (Fig. 1, Table 1). To achieve optimal 
conditions the size of the amplicon was kept small (92 bp). As an internal standard for quantitation and 
for quality control of the template DNA a part of the house keeping gene cyclophilin was co-amplified. 
There was no interference between both real-time PCRs as confirmed by an analysis of serial dilutions 
of genomic DNA from one pig, which was PERV-C positive. The PCR showed an efficacy of 93.7% for 
cyclophilin and 99.3% for envPERV-C (Fig. 3). The detection limit of the real-time PCR was 100 
copies as determined by a plasmid standard and a linear co-amplification was obtained between 1 pg 






3.3. Screening for PERV-C negative animals 
In total, 38 transgenic and non-transgenic landrace pigs from different sources were analysed using 
standard PCR, nested PCR and the real-time PCR. As shown above, 35 of 38 animals were tested 
positive by PCR1, PCR2 and PCR3 (Table 2). When the DNA from the PERV-C positive animals was 
analysed by real-time PCR, the signals for PERV-C and cyclophilin (cyp) appeared at the same cycle 
threshold value (ct-value approximately 25, Fig. 3). Real-time PCR was also used to analyse DNA 
from ear biopsies and DNA from PBMCs which gave varying results in the nested PCR. Both DNA 
samples originated from the same animal (see above). In case of DNA originating from ear biopsies 
the ct-value of the PERV-C signal was much higher compared to the ct-value of cyclophylin (between 
35 and 40 compared to 25, Fig. 3), indicating that there is less than one copy per genome. At the 
same time real-time PCR of the DNA from PBMCs confirmed the absence of PERV-C. This indicates 
that PERV-C is not endogenous in these animals and therefore represents a contamination, possibly 
by cells from neighbour PERV-C positive pigs or by a contamination due to the instrument used for 
taking biopsies. This means, the real-time method may also be used to discriminate between 
contaminations with DNA or cells from PERV-C positive animals on the one hand and presence of an 
integrated endogenous provirus on the other hand. Calculation of copy numbers revealed 1 to 7 
PERV-C copies per genome in PERV-C positive animals and less than 1 copy in 300 genomes in the 
case of contaminations. 
 
3.4. Confirmation by sequencing 
Genomic DNA from PERV-C positive animals (three transgenic animals and two farm pigs) were 
amplified using PCR3 and the amplification products were sequenced. As a result, the sequences 
were found identical to the sequences shown in Fig. 1, indicating that the proviral PERV-C sequences 
were identical at least in this region. 
 
4. Discussion 
Different methods were developed to screen for the presence of PERV-C proviruses in the genome of 
farm pigs and of transgenic pigs bred for xenotransplantation. These methods include five standard 
PCR using different primer pairs, a nested PCR and a real-time PCR. Using these methods, 35 of 38 
(92%) non-transgenic and transgenic animals were found to carry PERV-C in their genome, confirming 
a previous study in which 176 of 181 animals (92%) were PERV-C positive (Dieckhoff et al., 2009). 
The transgenic animals studied here expressed different genes that should reduce hyperacute and 
vascular rejection such as hHO-1, hA20, CD59, DAF or represent GalKO knockout animals (Table 2). 
Although the number of PERV-C negative pigs is low, these animals can be used as source for 
genetically modified animals designed for xenotransplantation. 
Since it was recommended not to use animals harbouring PERV-C in their genome in order to avoid 
PERV-A/C recombinations (Denner et al., 2009), these methods are instrumental for the detection of 
PERV-C free animals. PERV-A/C were until now detected only in miniature pigs and in these animals 
only in certain organs, e.g., in the spleen, but not in other organs and never in the germ line ( 
[Bartosch et al., 2004], [Harrison et al., 2004] and [Dieckhoff et al., 2007]). PERV-A/C were also not 
found in the New Zealand designated pathogen-free herd (Garkavenko et al., 2008). However, there 
are new reports on PERV-A/C in commercially used pigs with an increased number in clinically 
affected animals (Pal et al., 2011). In addition, there are also other reasons not to use PERV-C 
positive animals. First, the ability of PERV-C to infect cells that do not harbor the specific receptor by 
receptor-independent infection (Lavillette and Kabat, 2004), and second, mutations in the envelope 
protein of PERV-C may change the tropism towards human cells (Gemeniano et al., 2006). These 
data indicate, that breeding out PERV-C will reduce the risk of PERV transmission in 
xenotransplantation. 
The methods are sensitive to detect up to 1.1 × 10
3
 copies per genome in the standard PCR1, 1 
copies per genome in the nested PCR and 100 molecules in the real-time PCR. The use of such 
sensitive methods may always be associated with the risk of contaminations and false positive results. 
Accordingly, a high risk of contamination was observed, when ear biopsies were used, either due to 
cells originating from other animals on the ear of the tested animal or on the instrument used for taking 
  
the biopsy. In general, a high sensitivity and at the same time a high specificity are important for the 
detection of retroviral infections. Recent reports showing infection with a murine retrovirus, XMRV 
(xenotropic murine leukemia virus-related virus), in patients with prostate carcinoma and chronic 
fatigue syndrome (CFS) as well as in healthy individuals in some laboratories in the USA, but not in 
Europe (for review see Denner, 2010) are an example underlining this requirement. At present there is 
overwhelming evidence that the detection of XMRV or other murine viruses in human tissues 
represents the result of laboratory contaminations by murine DNA or cells (Smith, 2010). Therefore, 
PCRs designed to detect retrovirus infections or proviruses of endogenous retroviruses should be 
performed under appropriate conditions and all necessary precautions should be undertaken. 
Based on these results, for an effective screening for PERV-C in pigs the use of blood samples (not 
ear biopsies, to avoid contaminations with cells from PERV-C positive animals) is recommended. The 
screening should start with PCR analyses such as PCR1. If the result is negative, mutations in the 
primer binding may be the reason and in this case PCR2 to PCR5 should be used. If PCR1 gives a 
positive result, a real-time PCR has to be performed to test for contamination in order to avoid false-
positive results. If PCR1 to PCR5 give a negative result, a nested PCR or the real-time PCR should be 
performed to detect animals with low copy numbers of PERV-C. 
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Tables and Figures 
 
 
Table 1. Primers and probes used for amplification in the nested PCR and real-time PCR. 
 
 
Table 2. Incidence of PERV provirus in nontransgenic and transgenic pigs. 
 
 
For details of the strains, the origin of the animals, the transgenes or GalKO, and the different PCR 




Figure 1.  (A) Schematic presentation of the location of the primers for the PCRs and the probe for the 
real-time PCR. The length of the amplicons in bp and the approximate localisation of the virus receptor 
domain A (VRA) and B (VRB) and the proline rich region (PRR) in the receptor binding site of the 
surface envelope protein of PERV-C are indicated. (B) Sequence comparison of part of the surface 
envelope protein of PERV-C (envC), PERV-A (envA) and PERV-B (envB). The sequences of the outer 
primers (PCR1) and inner primers (PCR2) of the nested PCR, primers of PCR 3, 4 and 5 as well as 




Figure 2. Determination of PERV-C copies in plasmid molecules. The sensitivity of plasmid molecules 
of molecular clone PERV-C(1312) (Preuss et al., 2006) was estimated. (A) Standard PCR (PCR1); (B) 
nested PCR using outer primers (PCR1) and inner primers (PCR2). Each sample contains 100 ng 




Figure 3. (A) Estimation of the efficacy of the duplex real-time PCR. Dilutions of the PERV-C env 
clone (99.3% efficacy) and of a cyclophiline plasmid (93.7% efficacy) were measured. (B) and (C) 
Results of the real-time PCR amplification of cyclophiline (B) and PERV-C env (C). All control PCR (B, 
cyclophiline, Cy5-signal) showed a ct-value of approximately 29, in the PERV-C measurement (C, 
FAM-signal) most samples showed endogenous PERV with a ct-value of 29, some samples showed 
contaminations with higher ct-values. 
 
